[1] VAN OIRSCHOT J T.Vaccinology of classical swine fever:from lab to field[J].Vet Microbiol,2003,96(4):367-384. [2] HULST M M,VAN GENNIP H G,VLOT A C,et al.Interaction of classical swine fever virus with membrane-associated heparan sulfate:role for virus replication in vivo and virulence[J].J Virol,2001,75(20):9585-9595. [3] 殷 震,刘景华.动物病毒学[M].2版.北京:科学出版社,1997:645-664. YIN Z,LIU J H.Animal virology[M].2nd ed.Beijing:Science Press,1997:645-644.(in Chinese) [4] RUGGLI N,MOSER C,MITCHELL D,et al.Baculovirus expression and affinity purification of protein E2 of classical swine fever virus strain Alfort/187[J].Virus Genes,1995,10(2):115-126. [5] DONG X N,CHEN Y H.Marker vaccine strategies and candidate CSFV marker vaccines[J].Vaccine,2007,25(2):205-230. [6] 王 琴,涂长春.猪瘟[M].北京:中国农业出版社,2015:30-32. WANG Q,TU C C.Classical swine fever[M].Beijing:China Agriculture Press,2015:30-32.(in Chinese) [7] EDWARD S,SANDS J J.Antigenic comparisons of hog cholera virus isolates from Europe,America and Asia using monoclonal antibodies[J].Dtsch Tierarztl Wochenschr,1990,97(2):79-81. [8] IN ML,LIN F,MALLORY M,et al.Deletions of structural glycoprotein E2 of classical swine fever virus strain Alfort/187 resolve a linear epitope of monoclonal antibody WH303 and the minimal N-terminal domain essential for binding immunoglobulin G antibodies of a pig hyperimmune serum[J].J Virol,2000,74(24):11616-11625. [9] HOLINKA L G,FERNANDEZ-SAINZ I,O'DONNELL V,et al.Development of a live attenuated antigenic marker classical swine fever vaccine[J].Virology,2009,384(1):106-113. [10] HOLINKA L G,FERNANDEZ-SAINZ I,SANFORD B,et al.Development of an improved live attenuated antigenic marker CSF vaccine strain candidate with an increased genetic stability[J].Virology,2014,471-473:13-18. [11] 韩 焘.猪瘟兔化弱毒标记株感染性克隆的构建与病毒拯救[D].北京:中国兽医药品监察所,2011. HAN T.Construction infectious cDNA of markered classical swine fever virus C strain and virus rescue[D].Beijing:China Institute of Veterinary Drugs Control,2011.(in Chinese) [12] 邹兴启,赵启祖,范运峰,等.猪瘟病毒C株全长cDNA感染性克隆的构建及病毒拯救[J].中国农业科学,2011,44(2):409-416. ZOU X Q,ZHAO Q Z,FAN Y F,et al.Construction of the full length infectious cDNA clones of CSFV C strain and virus rescue[J].Scientia Agricultura Sinica,2011,44(2):409-416.(in Chinese) [13] 朱元源,韩 焘,邹兴启,等.猪瘟病毒石门重组标记毒株的构建与拯救[J].中国农业科学,2013,46(1):187-194. ZHU Y Y,HAN T,ZOU X Q,et al.Construction and rescue of recombinant classical swine fever virus with Shimen structure protein and flag marker[J].Scientia Agricultura Sinica,2013,46(1):187-194.(in Chinese) [14] 王 琴,徐 璐,张乾义,等.一种抗猪瘟病毒E2蛋白单克隆抗体细胞株及其应用:中国,107058239[P].2017-08-18. WANG Q,XU L,ZHANG Q Y,et al.A monoclonal antibody cell line against E2 protein of swine fever virus and its application:CN,107058239[P].2017-08-18.(in Chinese) [15] TRATSCHIN J D,MOSER C,RUGGLI N,et al.Classical swine fever virus leader proteinase Npro is not required for viral replication in cell culture[J].J Virol,1998,72(9):7681-7684. [16] WENSVOORT G.Topographical and functional mapping of epitopes on hog cholera virus with monoclonal antibodies[J].J Gen Virol,1989,70(11):2865-2876. [17] WENSVOORT G,TERPSTRA C,DE KLUIJVER E P,et al.Antigenic differentiation of pestivirus strains with monoclonal antibodies against hog cholera virus[J].Vet Microbiol,1989,21(1):9-20. [18] WEILAND E,STARK R,HAAS B,et al.Pestivirus glycoprotein which induces neutralizing antibodies forms part of a disulfide-linked heterodimer[J].J Virol,1990,64(8):3563-3569. [19] 宁宜宝,吴文福,林旭埜,等.用细胞系生产猪瘟活疫苗的方法:中国,100577204C[P].2010-01-06. NING Y B,WU W F,LIN X Y,et al.Method for producing live swine fever vaccine from cell lines:CN,100577204C[P].2010-01-06.(in Chinese) [20] VAN GENNIP H G P,VAN RIJN P A,WIDJOJOATMODJO M N,et al.Chimeric classical swine fever viruses containing envelope protein ERNS or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response[J].Vaccine,2000,19(4-5):447-459. [21] WIDJOJOATMODJO M N,VAN GENNIP H G P,[LL]BOUMA A,et al.Classical swine fever virus Erns deletion mutants:trans-complementation and potential use as nontransmissible,modified,live-attenuated marker vaccines[J].J Virol,2000,74(7):2973-2980. [22] REIMANN I,DEPNER K,TRAPP S,et al.An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus[J].Virology,2004,322(1):143-157. [23] RENSON P,LE DIMNA M,GABRIEL C,et al.Cytokine and immunoglobulin isotype profiles during CP7_E2alf vaccination against a challenge with the highly virulent Koslov strain of classical swine fever virus[J].Res Vet Sci,2014,96(2):389-395. [24] BLOME S,WERNIKE K,REIMANN I,et al.A decade of research into classical swine fever marker vaccine CP7_E2alf (Suvaxyn® CSF Marker):a review of vaccine properties[J].Vet Res,2017,48(1):51. [25] BLOME S,AEBISCHER A,LANGE E,et al.Comparative evaluation of live marker vaccine candidates "CP7_E2alf" and "flc11" along with C-strain "Riems" after oral vaccination[J].Vet Microbiol,2012,158(1-2):42-59. [26] GOLLER K V,DRÄGER C,HÖPER D,et al.Classical swine fever virus marker vaccine strain CP7_E2alf:genetic stability in vitro and in vivo[J].Arch Virol,2015,160(12):3121-3125. [27] HULST M M,HIMES G,NEWBIGIN E,et al.Glycoprotein E2 of classical swine fever virus:expression in insect cells and identification as a ribonuclease[J].Virology,1994,200(2):558-565. |